M-Fox Adds 20,000 Additional Doses of Preventive Vaccine for High-Risk Groups
On the 26th, the Korea Disease Control and Prevention Agency announced that it will urgently procure an additional 20,000 doses of the vaccine 'Jynneos' to prepare stably and long-term against Mpox (monkeypox).
After the first domestic Mpox case was confirmed in June last year, the government introduced 10,000 doses of Jynneos in August of the same year.
Since then, vaccinations have been administered mainly to medical personnel and contacts, but as confirmed cases increased this year, since May, vaccinations have been expanded to high-risk groups before exposure to risk.
Jynneos is an adult smallpox and Mpox prevention vaccine produced by Bavarian Nordic in Denmark. The additional quantity being procured this time was produced in November last year and has a validity period until November 30, 2031.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- [Breaking] Two Days Before Strike... Central Labor Relations Commission Chair Park Soogeun Says "Differences Narrowing... Possibility of Agreement"
- Individual Investors Absorb Foreign Sell-Off... Concerns Over Becoming "Cannon Fodder" Emerge
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
Since the first presumed domestic infection case of Mpox in April, the number of confirmed cases in Korea has been counted as 115 as of the 22nd.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
